Materials
All chemicals were obtained from commercial sources and used without further purification. O-Acetyl-L-serine hydrochloride, triphosgene, lithium hydroxide, pyridinium p-toluenesulfonate (PPTS), Pluronic® F-127, glucose oxidase (GOx) and bovine catalase (CAT) were purchased from Sigma Aldrich. Poly(ethylene glycol) amine (PEG2000-NH 2 ) was ordered from Laysan Bio, Inc. (USA). 2-ethoxy-1-propene was obtained from Synthonix Inc.. Recombinant human insulin (Zn salt, 27.5 IU/mg) was purchased from Life Technologies (USA). All the organic solvents for synthesis and analysis were ordered from Fisher Scientific Inc. and used as received.
Chemical labeling of insulin with Oregon Green

® 488
Thirty milligrams of Insulin were dissolved in 5 mL of dry DMSO. After insulin was completely dissolved, Oregon Green ® 488 (1 mg, Life tech, Inc) was added into the solution. The reaction was initiated by adding 20 µL of triethylamine. After 24 hours, the reaction was poured into the distilled water (10 mL). The yellow solution was then dialysis against DD water and lyophilized. The molecular weight of chemical labeled insulin was measured by MALDI-TOF ( Figure S10 ).
Preparation and analysis of nanovesicle by Confocal Laser Scanning Microscopy
The Oregon Green ® 488 labeled insulin was encapsulated into the nanovesicle as described above. The diluted vesicle solution was transferred into the confocal microscopy dish (MatTek Corp.). The confocal image was taken using Confocal Laser Scanning Microscopy (Zeiss, LSM710). The excitation and emission wavelength were set at 488 nm and 518 nm, respectively. The image was analyzed and overlayed using Image J software.
GOx stability study
To confirm the stability of GOx during the polymersome-preparation process, the catalytic bioactivity of the treated GOx was compared with the native enzyme by measuring their pH-decreasing ability in glucose saline.
After the THF evaporation during polymersome preparation, the supernatant of the polymersome suspension, which represents the un-encapsulated GOx/CAT solution, was collected and considered as the treated GOx/CAT enzymes. The native GOx/CAT and the treated enzymes were diluted to 0.2 mg/ml GOx with 400 mg/dL glucose saline, separately. The enzyme glucose solutions were incubated at 37 o C and their pH value was closely monitored as the function of time using pH meter (Fisher Scientific, AB15).
The stability of polymersome in PF127 thermogel
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The stability of polymersome in PF127 thermogel was evaluated by measuring the insulin leakage during the gelation. Briefly, the insulin encapsulated polymersome was suspended into the ice-cold 30% PF127 solution, which was then warmed to 37 o C for gelation. Twenty-four hours after incubation at 37 o C, the hydrogel was cooled to 4 o C and liquefied. The polymersome was spin down and the supernatant was collected to quantify the released insulin. Figure S1 . Schematic of enzymatic reaction with glucose oxidase (GOx) and catalase (CAT), together with its effect on ketal hydrolysis. GOx converts glucose into gluconic acid and hydrogen peroxide (H 2 O 2 ) by consuming oxyogen (O 2 ), while CAT. breaks down harmful H 2 O 2 into water and O 2 . Gluconic acid decreases the local pH value and hydrolyzes the ketal containing polymer, leading to nanovesicle dissociation. 
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